VDR and neoplasm: The active form of VD, 1α,25-(OH)2D3, inhibits tumour growth [15]; additionally, through binding to the VD receptor (VDR), it plays a transcriptional regulatory role by facilitating the combination of its DNA-binding domain with VD response elements in target genes [16, 17].